Spectacle lens prescriptions provided by optometrists. (FE)
Impact
The bill specifically mandates that spectacle lens prescriptions must contain certain details, including a measurement of the patient's pupillary distance, which is not currently required under the existing rules. By establishing these requirements in statute rather than merely allowing the Optometry Examining Board to set rules, the bill could lead to increased transparency and accountability in the optometric profession. As a result, patients may have improved access to their prescriptions, potentially fostering competition among vendors and greater consumer choice.
Summary
Assembly Bill 1226 aims to codify measures regarding the issuance of spectacle lens and contact lens prescriptions by optometrists in Wisconsin. This bill defines unprofessional conduct for optometrists to include the failure to provide patients with their lens prescriptions at no cost after the completion of contact lens fittings and initial follow-up care. The inclusion of such provisions seeks to enhance patient access to necessary prescriptions, allowing for greater autonomy in selecting eyewear and contact lenses from various vendors.
Contention
However, there may be points of contention regarding the enforcement of these provisions and the potential for increased disciplinary actions against optometrists who fail to comply. Critics might argue that the bill could lead to administrative burdens for optometrists and that the exact requirements may constrain professional judgment or lead to confusion over compliance. Proponents will likely emphasize the importance of patient rights and access to prescriptions, framing the bill as a necessary step towards patient empowerment in healthcare decisions.
Health: occupations; examination and evaluation for purchase of contact lenses; allow to be in person or by telemedicine. Amends secs. 5553, 5555, 5557 & 5561 of 1978 PA 368 (MCL 333.5553 et seq.) & adds secs. 5560 & 5562.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.